Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial
Author(s) -
Saoussen Ben Abdallah,
Yosra Mhalla,
Imen Trabelsi,
Adel Sekma,
Rim Youssef,
Khaoula Bel Haj Ali,
Houda Ben Soltane,
Hajer Yacoubi,
Mohamed Amine Msolli,
Nejla Stambouli,
Kaouthar Beltaïef,
Mohamed Habib Grissa,
Meriem Khrouf,
Zied Mezgar,
C. Loussaief,
Wahid Bouida,
Rabie Razgallah,
Karima Hezbri,
Asma Sriha Belguith,
Naouel Belkacem,
Zohra Dridi,
Hamdi Boubaker,
Riadh Boukef,
Semir Nouira
Publication year - 2022
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac807
Subject(s) - medicine , placebo , randomization , randomized controlled trial , intensive care unit , comorbidity , adverse effect , clinical endpoint , ambulatory , alternative medicine , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom